SAMANTHA HALL: Open Payments
NPI 1942920343 · LECANTO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$247 in 12 payments from 6 companies in 2025. Trend: 2023 $358 · 2024 $254 · 2025 $247
Food & beverage: $247
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| ABBVIE INC. | 3 | $68 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
| Amgen Inc. | 2 | $33 |
| PFIZER INC. | 1 | $25 |
| Novo Nordisk Inc | 1 | $19 |
Products named: CAPLYTA, VRAYLAR, Jornay PM, ELIQUIS, UBRELVY, Wegovy, OTEZLA, Repatha.
Industry payments across FL — which companies pay providers there.
